Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Cogent Biosciences (COGT) Return on Equity (2018 - 2021)

Cogent Biosciences has reported Return on Equity over the past 4 years, most recently at 0.3% for Q3 2021.

  • Quarterly results put Return on Equity at 0.3% for Q3 2021, down 4692.0% from a year ago — trailing twelve months through Sep 2021 was 0.3% (down 4692.0% YoY), and the annual figure for FY2020 was 0.62%, up 8.0%.
  • Return on Equity for Q3 2021 was 0.3% at Cogent Biosciences, up from 0.45% in the prior quarter.
  • Over the last five years, Return on Equity for COGT hit a ceiling of 46.62% in Q3 2020 and a floor of 3.89% in Q2 2018.
  • Median Return on Equity over the past 4 years was 0.72% (2019), compared with a mean of 2.29%.
  • Biggest five-year swings in Return on Equity: skyrocketed 4787bps in 2020 and later crashed -4692bps in 2021.
  • Cogent Biosciences' Return on Equity stood at 0.55% in 2018, then crashed by -94bps to 1.06% in 2019, then grew by 27bps to 0.77% in 2020, then skyrocketed by 62bps to 0.3% in 2021.
  • The last three reported values for Return on Equity were 0.3% (Q3 2021), 0.45% (Q2 2021), and 0.38% (Q1 2021) per Business Quant data.